The BC Bud Corporation
Digital Commodities Capital Corp. operates as an investment company that allocates capital into digital assets. The company invests in digital assets: cryptocurrencies; hard commodities, such as gold, silver, and non-fiat assets; and businesses and private and publicly listed entities via private placements. Digital Commodities Capital Corp. was formerly known as The BC Bud Corporation and change… Read more
The BC Bud Corporation (BCBCF) - Net Assets
Latest net assets as of November 2024: $460.66K USD
Based on the latest financial reports, The BC Bud Corporation (BCBCF) has net assets worth $460.66K USD as of November 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($960.13K) and total liabilities ($499.47K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $460.66K |
| % of Total Assets | 47.98% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 87.6 |
The BC Bud Corporation - Net Assets Trend (2020–2024)
This chart illustrates how The BC Bud Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for The BC Bud Corporation (2020–2024)
The table below shows the annual net assets of The BC Bud Corporation from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-02-29 | $6.06K | -99.52% |
| 2023-02-28 | $1.26 Million | -28.69% |
| 2022-02-28 | $1.77 Million | +111.32% |
| 2021-02-28 | $838.41K | +1717.15% |
| 2020-02-29 | $-51.84K | -- |
Equity Component Analysis
This analysis shows how different components contribute to The BC Bud Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 501454300.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (February 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.97 Million | 81917.27% |
| Other Components | $594.33K | 9804.11% |
| Total Equity | $6.06K | 100.00% |
The BC Bud Corporation Competitors by Market Cap
The table below lists competitors of The BC Bud Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SRJ Technologies Group Plc
AU:SRJ
|
$3.33 Million |
|
Kiplin Metals Inc
PINK:ALDVF
|
$3.33 Million |
|
Tego Cyber Inc
PINK:TGCB
|
$3.33 Million |
|
Sonim Technologies Inc
NASDAQ:SONM
|
$3.34 Million |
|
Isra Presisi Indonesia
JK:ISAP
|
$3.33 Million |
|
NEWMARK SECURITY LS-005
F:NN10
|
$3.33 Million |
|
Polwax S.A
F:1LW
|
$3.33 Million |
|
Norfolk Metals Ltd
AU:NFL
|
$3.33 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in The BC Bud Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,263,314 to 6,062, a change of -1,257,252 (-99.5%).
- Net loss of 1,224,056 reduced equity.
- New share issuances of 198,500 increased equity.
- Other factors decreased equity by 231,696.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.22 Million | -20192.28% |
| Share Issuances | $198.50K | +3274.5% |
| Other Changes | $-231.70K | -3822.1% |
| Total Change | $- | -99.52% |
Book Value vs Market Value Analysis
This analysis compares The BC Bud Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 239.45x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-02-29 | $-0.01 | $0.03 | x |
| 2021-02-28 | $0.08 | $0.03 | x |
| 2022-02-28 | $0.04 | $0.03 | x |
| 2023-02-28 | $0.02 | $0.03 | x |
| 2024-02-29 | $0.00 | $0.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently The BC Bud Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -20192.28%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1990.92%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 104.27x
- Recent ROE (-20192.28%) is below the historical average (-4096.52%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | -5225.03% | 0.07x | 0.00x | $-287.31K |
| 2021 | -17.08% | -42505.04% | 0.00x | 1.06x | $-227.08K |
| 2022 | -161.30% | -1892598.01% | 0.00x | 1.10x | $-3.03 Million |
| 2023 | -111.91% | -525.12% | 0.17x | 1.29x | $-1.54 Million |
| 2024 | -20192.28% | -1990.92% | 0.10x | 104.27x | $-1.22 Million |
Industry Comparison
This section compares The BC Bud Corporation's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| The BC Bud Corporation (BCBCF) | $460.66K | 0.00% | 1.08x | $3.33 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |